Patents by Inventor Miquel Taron Roca

Miquel Taron Roca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN FOR NON-SMALL-CELL LUNG CANCER BASED ON BRCA1 EXPRESSION
    Publication number: 20100009013
    Abstract: The present invention relates to a screening method for classifying patients and for selecting an effective chemotherapy for the treatment of a patient suffering from non-small-cell lung cancer (NSCLC), based on the use of his levels of BRCA1 expression to predict the outcome of chemotherapy.
    Type: Application
    Filed: July 1, 2009
    Publication date: January 14, 2010
    Applicant: PANGAEA BIOTECH
    Inventors: Rafael ROSELL COSTA, Miquel TARON ROCA
  • Method of determining a chemotherapeutic regimen for non small cell lung cancer based on BRCA1 expression
    Patent number: 7563570
    Abstract: The present invention relates to a screening method for classifying patients and for selecting an effective chemotherapy for the treatment of a patient suffering from non-small-cell lung cancer (NSCLC), based on the use of his levels of BRCA1 expression to predict the outcome of chemotherapy.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: July 21, 2009
    Assignee: Pangaea Biotech
    Inventors: Rafael Rosell Costa, Miquel Taron Roca